Abstract:Objective: Maintaining a constant core body temperature is essential to homeothermic vertebrate survival. Adaptive thermogenesis in brown adipose tissue and skeletal muscle is the primary mechanism of adjustment to an external stimulus such as cold exposure. Recently, several reports have revealed that the liver can play a role as a metabolic hub during adaptive thermogenesis. In this study, we suggest that the liver plays a novel role in secreting thermogenic factors in adaptive thermogenesis. Bone morphogenetic protein 9 (BMP9) is a hepatokine that regulates many biological processes, including osteogenesis, chondrogenesis, hematopoiesis, and angiogenesis. Previously, BMP9 was suggested to affect preadipocyte proliferation and differentiation. However, the conditions and mechanisms underlying hepatic expression and secretion and adipose tissue browning of BMP9 remain largely unknown. In this study, we investigated the physiological conditions for secretion and the regulatory mechanism of hepatic Bmp9 expression and the molecular mechanism by which BMP9 induces thermogenic gene program activation in adipose tissue. Here, we also present the pharmacological effects of BMP9 on a high-fat-induced obese mouse model. Methods: To investigate the adaptive thermogenic role of BMP9 in vivo, we challenged mice with cold temperature exposure for 3 weeks and then examined the BMP9 plasma concentration and hepatic expression level. The cellular mechanism of hepatic Bmp9 expression under cold exposure was explored through promoter analysis. To identify the role of BMP9 in the differentiation of brown and beige adipocytes, we treated pluripotent stem cells and inguinal white adipose tissue (iWAT)-derived stromal-vascular (SV) cells with BMP9, and brown adipogenesis was monitored by examining thermogenic gene expression and signaling pathways. Furthermore, to evaluate the effect of BMP9 on diet-induced obesity, changes in body composition and glucose tolerance were analyzed in mice administered recombinant BMP9 (rBMP9) for 8 weeks. Results: Hepatic Bmp9 expression and plasma levels in mice were significantly increased after 3 weeks of cold exposure. Bmp9 mRNA expression in the liver was regulated by transcriptional activation induced by cAMP response-element binding protein (CREB) and CREB-binding protein (CBP) on the Bmp9 promoter. Treatment with BMP9 promoted the differentiation of multipotent stem cells and iWAT-derived SV cells into beige adipocytes, as indicated by the increased expression of brown adipocyte and mitochondrial biogenesis markers. Notably, activation of the mothers against decapentaplegic homolog 1 (Smad1) and p44/p42 mitogen-activated protein kinase (MAPK) pathways was required for the induction of uncoupling protein 1 (UCP1) and peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC1α) expression in BMP9-induced differentiation of SVs into beige adipocytes. The administration of rBMP9 in vivo also induced browning markers in white adipose tissue. In high-fat diet-induced obese mice, rBMP9 administration conferred protection against obesity and enhanced glucose tolerance. Conclusions: BMP9 is a hepatokine regulated by cold-activated CREB and CBP and enhances glucose and fat metabolism by promoting the activation of the thermogenic gene program in adipocytes. These data implicate BMP9 as a potential pharmacological tool for protecting against obesity and type 2 diabetes.

CRISPR-mediated BMP9 Ablation Promotes Liver Steatosis Via the Down-Regulation of PPARα Expression

The Role of Bone Morphogenetic Protein 9 in Nonalcoholic Fatty Liver Disease in Mice

Abstract 89: A TGF-beta Pathway-SREBP1 Axis Controls Liver Diseases from Nonalcoholic Steatohepatitis to Hepatocellular Carcinoma

Bone Morphogenetic Protein 4 (BMP4) Alleviates Hepatic Steatosis by Increasing Hepatic Lipid Turnover and Inhibiting the Mtorc1 Signaling Axis in Hepatocytes

Targeting Secreted Cytokine BMP9 Gates the Attenuation of Hepatic Fibrosis.

Bone morphogenic protein 9 is a novel thermogenic hepatokine secreted in response to cold exposure

BMP-9 Interferes with Liver Regeneration and Promotes Liver Fibrosis.

Bone Morphogenetic Protein 9 As a Key Regulator of Liver Progenitor Cells in DDC‐induced Cholestatic Liver Injury

Bmp8a deletion leads to obesity through regulation of lipid metabolism and adipocyte differentiation

Neutralization of Bone Morphogenetic Protein (BMP)–9 in Mouse Liver Reduces CCl–4 Mediated Fibrogenesis

Effect of Mirna-10b in Regulating Cellular Steatosis Level by Targeting Ppar-Alpha Expression, A Novel Mechanism for the Pathogenesis of Nafld

Aquaporin-9 downregulation prevents steatosis in oleic acid-induced non-alcoholic fatty liver disease cell models.

Potential Roles Of Bmp9 In Liver Fibrosis

BMP9 Action in the Hypothalamus Suppresses Hepatic Glucose Production Through a Central PI3K/Akt /mtor Pathway

Histone Methyltransferase G9a Regulates Expression of Nuclear Receptors and Cytochrome P450 Enzymes in HepaRG Cells at Basal Level and in Fatty Acid Induced Steatosis

Effect of miR-34a in regulating steatosis by targeting PPARα expression in nonalcoholic fatty liver disease

FGF9 Alleviates the Fatty Liver Phenotype by Regulating Hepatic Lipid Metabolism.

Intestinal BMP-9 locally upregulates FGF19 and is down-regulated in obese patients with diabetes

[KLF9 Regulates Hepatic Lipid Metabolism Via Inducing CD36 Expression].

Hepatic DNAJB9 Drives Anabolic Biasing to Reduce Steatosis and Obesity

Expression, signalling and potential in vivo functions of Bone Morphogenetic Protein (BMP)-9 in the liver